Peripheral blood T regulatory cell counts may not predict transplant rejection.

BMC Immunology
Yuchuan HuangYouping Li

Abstract

Recent evidence shows that allograft survival rates show a positive correlation with the number of circulating T regulatory cells (Tregs). This study investigated both the number and the cytokine profiles exhibited by Foxp3+ Tregs in blood, spleen and lymph nodes of Lewis rat recipients of BN rat cardiac allografts after a single-dose of Rapamycin (RAPA). Rats were divided into three groups: control group (containing healthy control and acute rejection group), and recipients treated with a single dose of RAPA on either Day 1 (1D group)or Day 3 (3D group) post-transplant. We analyzed the number of Foxp3+Tregs and the expression of Foxp3 and cytokines in the peripheral blood and the peripheral lymphoid tissues. No difference was found in the numbers of circulating Foxp3+ Tregs between these three groups. RAPA administration significantly increased Foxp3 expression in peripheral lymphoid tissues after a single dose of RAPA on Day 3 post-transplant. Foxp3+Tregs inhibited the activity of effector T cells (Teff) via the secretion of TGF-beta1. The number of Tregs in the recipient's blood may not be a good predictor of transplant rejection. Foxp3+Tregs inhibit the activity of Teff cells mainly in the peripheral lymphoid tissues.

References

Feb 1, 1969·The Journal of Thoracic and Cardiovascular Surgery·K Ono, E S Lindsey
Mar 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M HaraK J Wood
Dec 26, 2001·Transplantation Proceedings·K J WoodP J Morris
Jun 5, 2002·The Journal of Experimental Medicine·Leonid GorelikRichard A Flavell
Jun 19, 2002·The Journal of Experimental Medicine·Luis GracaHerman Waldmann
Jan 8, 2003·The Journal of Experimental Medicine·Kevin J MaloyFiona Powrie
Mar 27, 2003·Nature Reviews. Immunology·Kathryn J Wood, Shimon Sakaguchi
Mar 5, 2005·Blood·Manuela BattagliaMaria-Grazia Roncarolo
Feb 1, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Ahmet DemirkiranLuc J W van der Laan
Aug 15, 2006·Immunological Reviews·Maria Grazia RoncaroloMegan K Levings
Jan 24, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Caroline Schmidt-LuckeStefanie Dimmeler
May 22, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·W GaoT B Strom
Nov 21, 2007·Nature Immunology·Alexander ScheffoldThomas Höfer
Aug 21, 2009·The Journal of Surgical Research·Juan ShanYouping Li
Jun 5, 2013·Cold Spring Harbor Perspectives in Medicine·Stephen P Cobbold, Herman Waldmann

❮ Previous
Next ❯

Citations

Dec 6, 2016·International Journal of Environmental Research and Public Health·Wan-Ning TsengHo-Chang Kuo

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
PCR

Related Concepts

Related Feeds

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.